About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Digital Therapy for Fatty Liver Disease

NCT07007741·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

NAFLD patient (CAP value \>248 (dB/m))
Age 18-65 years old, 24kg/m2 ≤ BMI ≤ 35kg/m2
Must be able to use smartphone

You may not be if

Inherited metabolic or autoimmune liver disease
Drug/toxic/alcoholic/biliary liver injury, cirrhosis or any end-stage liver disease
Hepatic or extrahepatic malignant tumours
Pregnant and lactating women
Patients considered ineligible by the investigator's clinical judgment

The record

StatusActive not recruiting

PhaseNo phase

Taking part141

StartedNov 2022

UpdatedAug 12, 2026

Conditions

Steatohepatitis, Nonalcoholic Nonalcoholic Fatty Liver

Where1

XinHua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China

Clareo Health | Digital Therapy for Fatty Liver Disease